Fig. 4From: Transcriptional activator DOT1L putatively regulates human embryonic stem cell differentiation into the cardiac lineageDOT1L expression in (a) KIND1 and (b) HES3 cells after DOT1L siRNA treatment. About 70–75% DOT1L knockdown was achieved by DOT1L siRNA treatment in both KIND1 and HES3 cell lines compared to mock control. Error bars represent ±SEM. Knockdown is a result of three independent experiments. D dayBack to article page